
    
      This study is halting accrual at the end of the phase 1 portion of the study as data from the
      phase I study suggest that an alternative approach for the phase 2 portion of the study be
      undertaken. A newly designed Phase II trial is being developed and will be submitted as a new
      study protocol.
    
  